0 followers
Cirius Therapeutics is a clinical-stage company that develops insulin sensitizer for the treatment of non-alcoholic steatohepatitis. The company developing MSDC-0602K, a next-generation insulin sensitizer for the treatment of nonalcoholic steatohepatitis (NASH). MSDC-0602K is currently being evaluat... Read more
Charlie Health
5 followers
Tessera Therapeutics
2 followers
Vaxcyte
2 followers
Tarsus Pharmaceuticals
1 follower
Artiva Biotherapeutics
1 follower
Johnson & Johnson
420 followers
Abbott
278 followers
Thermo Fisher Scientific
158 followers
CRISPR Therapeutics
9 followers
Adverum Biotech
8 followers
Legend Biotech
5 followers
Explore companies